human
parainfluenza
virus
envelop
singlestrand
negativesens
rna
virus
paramyxovirida
famili
account
signific
amount
human
respiratori
ill
especi
infant
children
hematopoiet
cell
transplant
patient
immunocompromis
individu
human
parainfluenza
viru
commonli
isol
parainfluenza
viru
recent
becom
clear
process
wherebi
bind
enter
host
cell
fine
tune
interact
correct
host
cell
environ
two
surfac
glycoprotein
hemagglutininneuraminidas
hn
fusion
f
protein
work
concert
mediat
fusion
target
host
cell
infect
hn
tetram
carri
sever
function
addit
serv
receptor
bind
protein
viru
bind
sialic
acid
hn
bound
receptor
activ
f
fusion
readi
state
activ
f
insert
target
membran
undergo
seri
conform
chang
lead
fusion
structur
rearrang
f
protein
drive
cellassoci
fusion
peptid
toward
viral
membran
bring
two
membran
proxim
facilit
membran
fusion
viral
entri
hn
also
stabil
prefus
state
f
prior
receptor
engag
cleav
receptor
via
neuraminidas
activ
viral
bud
properti
act
togeth
infect
target
cell
hn
must
signal
f
protein
induc
seri
conform
shift
f
result
fusion
viral
membran
host
cell
membran
correct
time
place
highli
special
human
airway
microenviron
critic
function
place
hn
protein
hnf
fusion
complex
signific
select
pressur
featur
hn
balanc
pro
antifus
properti
hnf
fusion
complex
modul
fit
infect
human
mean
studi
rel
abil
replic
given
host
tissu
signific
differ
properti
govern
hn
hnf
interact
exist
cultur
laboratori
clinic
strain
hn
f
protein
differ
point
requir
infect
environ
adapt
cultur
via
increas
fusion
activ
whether
hn
increas
avid
receptor
enhanc
activ
f
reduc
receptor
cleavag
result
enhanc
receptor
contact
fusion
evalu
panel
clinic
strain
deep
sequenc
without
passag
immort
monolay
cultur
grown
primari
human
airway
epithelium
hae
function
differ
hnf
fusion
complex
phenotyp
less
activ
fusion
activ
clinic
virus
preserv
function
featur
panel
clinic
isol
growth
human
airway
suggest
mitig
fusion
may
import
fit
vivo
stark
differ
pressur
exert
vitro
vivo
condit
notabl
consequ
observ
character
system
addit
exampl
passag
influenza
viru
egg
vaccin
product
result
adapt
alter
antigen
cell
cultur
adapt
hepat
c
viru
impair
fit
vivo
studi
delin
import
character
clinic
virus
well
need
investig
viral
evolut
authent
tissu
biolog
signific
adapt
fact
base
evalu
set
clinic
strain
compar
laboratori
strain
avail
sequenc
hypothes
adapt
cultur
condit
might
occur
rapidli
virtu
grow
virus
sequenc
strain
publish
clinic
may
actual
alter
suit
cultur
cell
could
longer
consid
clinic
strain
rel
dearth
sequenc
inform
avail
hpiv
compar
respiratori
virus
importantli
lack
inform
strain
prior
passag
laboratori
therebi
subject
select
pressur
address
question
featur
associ
fit
human
may
lost
routin
viral
cultur
sought
understand
genom
chang
associ
brief
exposur
clinic
sampl
cultur
isol
process
use
metagenom
nextgener
sequenc
mng
field
strain
isol
human
analyz
divers
common
circul
strain
genom
level
simultan
sequenc
pair
specimen
subject
cultur
viral
isol
sequenc
strategi
use
sequenc
clinic
strain
directli
without
passag
immort
cell
reli
design
sequencespecif
primer
may
amplifi
subset
sampl
case
mutat
deep
genom
sequenc
nine
set
pair
clinic
sampl
primari
nasal
swab
viral
transport
medium
cultur
isol
cultur
harvest
zero
passag
viru
led
discoveri
number
hn
mutat
associ
rapid
evolut
cultur
assess
frequenc
mutat
identifi
earlier
also
perform
deep
sequenc
clinic
sampl
cultur
isol
univers
washington
virolog
laboratori
allow
us
confirm
alter
associ
brief
exposur
cultur
viral
isol
almost
entir
found
sequenc
cultur
isol
found
commonli
within
popul
virus
isol
function
character
effect
sever
specif
hn
gene
mutat
found
cultur
isol
clinic
isol
ci
express
hnf
complex
recombin
virus
bear
mutat
cultureassoci
mutat
increas
fusion
promot
hnf
complex
result
support
notion
clinic
strain
differ
cultur
virus
balanc
fusion
properti
locat
residu
differ
brief
cultur
clinic
virus
point
specif
domain
relev
control
viral
entri
vivo
sequenc
data
correl
function
data
help
defin
flexibl
constraint
fusion
complex
data
provid
first
character
cultureassoci
hn
mutat
background
clinic
strain
directli
patient
sampl
show
even
transient
exposur
cultur
zero
passag
viru
act
isol
viru
associ
genom
evolut
may
significantli
affect
viral
protein
function
reflect
vivo
dynam
compar
sequenc
directli
patient
sequenc
brief
growth
cultur
nine
nasal
swab
sequenc
metagenom
pair
viral
isol
sequenc
initi
isol
rhesu
monkey
kidney
rhmk
cell
investig
variant
allel
minor
allel
frequenc
aros
cultur
nine
swab
includ
one
clinic
sampl
independ
cultur
twice
ten
viral
isol
sequenc
clinic
respiratori
sampl
test
posit
quantit
revers
transcriptionpcr
qrtpcr
cycl
threshold
either
sequenc
directli
metagenom
nextgener
sequenc
mng
without
exposur
cultur
grown
rhmk
cell
viral
isol
harvest
sequenc
choic
rhmk
cell
studi
base
fact
standard
cell
use
viral
isol
mani
diagnost
microbiolog
laboratori
would
allow
us
answer
question
whether
standard
process
lead
alter
virus
seven
nine
cultur
isol
harvest
day
cultur
virus
passag
beyond
initi
isol
sequenc
read
cultur
virus
analyz
mutat
chang
rel
consensu
genom
obtain
metagenom
sequenc
origin
clinic
sampl
without
exposur
cell
cultur
assembl
analyz
variant
minor
allel
frequenc
maf
total
nonsynonym
mutat
chang
maf
chang
respons
exposur
cell
cultur
found
across
nine
set
viral
isol
hn
protein
p
fisher
exact
test
fig
ten
mutat
found
outsid
hn
protein
four
found
p
protein
four
l
protein
two
f
protein
two
l
variant
increas
allel
frequenc
cultur
specimen
one
found
separ
viral
isol
perform
clinic
sampl
found
high
allel
frequenc
origin
clinic
sampl
fig
g
evolut
polymeras
complex
explor
separ
focu
current
paper
entri
complex
viral
isol
sampl
note
appear
previous
describ
hn
mutat
maf
day
cultur
fig
hn
previous
isol
laboratoryadapt
strain
associ
enhanc
fusion
promot
result
hn
ftrigger
function
two
independ
viral
isol
rhmk
cell
clinic
sampl
result
select
hn
variant
allel
viral
isol
rhmk
cell
sampl
hn
mutat
emerg
allel
frequenc
day
greatest
chang
allel
frequenc
brief
exposur
cultur
fig
previou
comparison
direct
clinic
isol
laboratoryadapt
strain
show
everi
clinic
strain
bore
asparagin
n
posit
laboratori
strain
bore
aspart
acid
posit
hn
deriv
clinic
isol
ci
show
neuraminidas
activ
hn
deriv
labadapt
strain
substitut
aspart
acid
posit
laboratori
strain
led
approxim
receptor
cleavag
laboratoryadapt
strain
suggest
asparagin
posit
essenti
high
propens
receptor
cleavag
field
strain
rapid
emerg
adapt
cultur
reduc
receptor
cleavag
remark
viral
isol
sampl
hn
mutat
adjac
residu
mention
aros
maf
fig
isol
sampl
site
contain
mutat
unlink
mutat
also
aros
isol
ie
found
exclus
separ
read
isol
also
result
select
novel
mutat
hn
hn
compris
cluster
posit
signific
alter
cultur
virus
fig
region
hn
correspond
cluster
posit
known
interest
entri
vivo
base
featur
independ
viral
isol
sampl
set
mutat
emerg
hn
residu
previous
unrecogn
relev
fit
hn
hn
mutat
link
mutat
describ
also
recov
viral
isol
fig
h
adjac
residu
anoth
previous
undescrib
hn
mutat
select
high
allel
frequenc
isol
low
level
isol
maf
maf
discuss
three
residu
describ
region
interest
base
previou
structur
analysi
hn
dimer
interfac
dissect
influenc
exert
background
hn
sequenc
clinic
viru
subsequ
cultur
adapt
gener
phylogenet
tree
base
amino
acid
substitut
distanc
hn
protein
clinic
sampl
fig
none
phylogenydetermin
mutat
among
direct
clinic
sampl
strain
locat
hn
receptor
bind
site
ii
second
dimer
interfac
domain
emerg
rapid
cultur
adapt
independ
viral
isol
sampl
produc
hn
mutat
also
aros
among
separ
lineag
place
allel
aros
pair
clinicalcultur
specimen
broader
context
sequenc
inform
use
mng
obtain
whole
genom
addit
strain
primari
viral
isol
passag
zero
viru
brief
exposur
cultur
viral
isol
remain
directli
patient
sampl
specimen
collect
see
tabl
supplement
materi
recombin
analysi
use
reveal
recombin
among
strain
similarli
nonseg
negativestrand
rna
virus
phylodynam
analysi
concaten
code
region
sequenc
strain
reveal
mean
mutat
rate
substitutionssiteyear
confid
interv
analysi
concaten
code
region
sequenc
complet
code
sequenc
cd
genbank
nt
databas
septemb
reveal
similar
mean
mutat
rate
substitutionssiteyear
confid
interv
similar
paramyxovirus
phylogenet
analysi
newli
sequenc
code
sequenc
reveal
multipl
lineag
present
clinic
sampl
cluster
time
collect
domin
featur
rather
sequenc
obtain
viral
isol
versu
clinic
sampl
fig
howev
examin
deep
sequenc
data
viral
isol
reveal
mutat
maf
residu
residu
select
pair
sampleisol
analysi
origin
clinic
sampl
isol
avail
none
clinic
sampl
sequenc
metagenom
contain
variant
residu
loci
strain
variant
residu
viral
isol
laboratoryadapt
strain
contain
variant
residu
maf
would
expect
reflect
consensu
sequenc
avail
publicli
addit
newli
deriv
genom
sequenc
also
examin
complet
partial
consensu
hn
sequenc
avail
genbank
nt
databas
august
total
search
cultureassoci
mutat
isol
cultureassoci
mutat
hn
protein
describ
appear
exclus
sequenc
cultur
isol
none
consensu
sequenc
ncbi
mutat
mutat
residu
rang
consensu
sequenc
mutat
appear
previous
sequenc
vast
major
occur
cultur
isol
note
even
sequenc
list
clinic
may
experienc
brief
exposur
cultur
condit
mutat
report
consensu
hn
sequenc
ncbi
three
instanc
alter
found
ncbi
genbank
one
recov
use
rtpcr
directli
clinic
specimen
outbreak
children
hospit
cancer
ward
barcelona
spain
summer
remain
two
mutat
report
like
cultureadapt
colleg
american
pathologist
profici
test
sampl
strain
genbank
access
primari
cultur
isol
japan
ddbj
access
map
residu
chang
hn
protein
aros
adapt
brief
cultur
onto
hn
protein
crystal
structur
fig
alter
local
dimer
interfac
previous
describ
critic
residu
hn
dimer
interfac
hn
role
receptor
engag
activ
f
identifi
secondari
sialic
acid
bind
receptor
cleavag
shown
top
hn
globular
head
dimer
interfac
diagram
fig
diagram
highlight
fact
like
make
contact
nac
modif
glycosyl
could
therefor
signific
effect
bind
shown
alter
enhanc
dimer
contact
associ
cultur
adapt
host
fit
correl
reduc
dimer
contact
residu
alter
residu
associ
cultur
condit
well
support
notion
site
intim
involv
mechan
wherebi
hn
activ
f
natur
host
mutat
describ
appear
cluster
oppos
side
dimer
interfac
rapid
emerg
alter
adapt
patient
cultur
suggest
role
viral
entri
natur
host
note
make
specif
contact
oppos
monom
mutat
would
chang
conform
loop
significantli
therebi
alter
contact
loop
understand
select
forc
affect
fit
next
analyz
biolog
properti
confer
cultureassoci
mutat
hn
character
influenc
specif
residu
function
hnf
fusion
complex
investig
whether
identifi
mutat
alter
hn
fusion
promot
abil
previous
observ
clinic
isol
introduc
seven
rapidli
emerg
mutat
background
wellcharacter
clinic
isol
hn
clinic
isol
pair
mutat
hn
protein
labadapt
f
ensur
could
observ
adequ
level
fusion
compar
function
sinc
clinic
isol
hn
f
pair
result
nearli
unobserv
level
fusion
fusion
promot
mutant
hnf
pair
quantifi
complement
assay
compar
wildtyp
clinic
isol
hn
ci
wt
pair
labadapt
f
fig
includ
influenza
viru
hemagglutinin
ha
f
pair
posit
control
fusion
previous
shown
hn
stabil
properti
prevent
f
trigger
increas
fusion
rel
ci
wt
would
expect
seen
fusion
exhibit
mutant
hnf
pair
consider
higher
ci
wt
hnf
pair
rang
increas
hn
increas
hn
observ
fusion
promot
increas
hn
mutant
examin
sever
interact
properti
hn
see
introduct
involv
process
assess
neuraminidas
receptor
cleavag
activ
also
quantifi
releas
receptorbear
erythrocyt
rbc
hnexpress
cell
measur
balanc
avid
receptorcleav
properti
neuraminidas
activ
measur
cleavag
acid
sodium
salt
hydrat
hn
fig
previous
describ
almost
cultureadapt
hn
mutant
display
lower
neuraminidas
activ
ci
wt
rang
roughli
rel
activ
mutant
increas
neuraminidas
activ
roughli
activ
rel
ci
wt
previous
shown
mutat
hn
confer
higher
receptor
avid
intrins
enhanc
trigger
f
therebi
augment
fusogen
effect
overrid
increas
receptor
cleavag
see
releas
assay
releas
bound
receptorbear
rbc
cell
surfac
hn
reflect
balanc
neuraminidas
activ
would
releas
bond
tether
cell
avid
hn
retain
bound
cell
fig
quantifi
amount
rbc
releas
sever
time
point
incub
ph
differ
hn
readili
observ
earliest
time
point
min
ci
wt
releas
wherea
mutant
hn
less
releas
reflect
either
higher
receptor
avid
lower
neuraminidas
activ
observ
two
separ
group
mutant
capabl
releas
rbc
rapidli
releas
roughli
releas
min
complet
releas
min
contrast
slowli
releas
group
consist
releas
min
releas
min
note
higher
receptor
avid
hn
overrid
higherthanwt
neuraminidas
activ
assess
relev
hn
adapt
context
authent
viru
determin
fit
cultureadapt
virus
immort
cell
human
airway
epithelium
hae
gener
recombin
virus
bear
hn
mutat
interest
genet
background
wellcharacter
clinic
viru
contain
enhanc
green
fluoresc
protein
egfp
cassett
p
gene
engin
viru
sequenc
full
confirm
mutat
interest
engin
virus
permit
us
evalu
outcom
select
term
impact
fit
hae
cultur
airliquid
interfac
immort
cell
monolay
cultur
infect
virus
bear
wildtyp
wt
ci
hn
ci
hn
ci
hn
ci
hn
ci
hn
ci
hn
express
egfp
compar
wt
ci
virus
bear
mutat
hn
show
infect
cell
cell
monolay
day
fig
arrow
point
exampl
individu
infect
cell
contrast
wt
infect
top
photo
infect
virus
bear
individu
hn
mutat
subsequ
photo
adapt
confer
superior
growth
cultur
cell
expect
wt
ci
viru
handicap
growth
day
compar
virus
bear
individu
mutat
hn
fig
yellow
squar
produc
detect
progeni
compar
titer
pfuml
virus
bear
singl
adapt
hn
mutat
growth
cell
reveal
clinic
viru
sever
handicap
monolay
cultur
mutat
emerg
rhmk
cultur
isol
process
confer
growth
monolay
cultur
wt
ci
show
neglig
fit
monolay
cultur
compar
adapt
virus
day
day
infecti
viru
releas
supernat
fluid
viru
cell
cultur
day
howev
adapt
mutat
appear
tabl
correl
increas
product
infecti
particl
fig
yellow
squar
hae
tissu
wt
growth
advantag
mutat
virus
show
individu
cultureadapt
hn
mutat
modestli
impair
infect
hae
fig
orang
circl
day
hae
infect
wt
ci
releas
infecti
particl
hae
apic
surfac
time
particl
releas
mutant
virus
expect
base
previou
studi
growth
hae
result
emerg
mutat
tabl
mechan
affect
respiratori
viruscel
interplay
context
human
fine
tune
environ
host
understand
natur
viral
infect
featur
govern
infect
transmiss
human
endeavor
analyz
field
strain
airway
tissu
shown
human
parainfluenza
viru
type
conclus
drawn
laboratori
strain
mislead
regard
receptor
interact
viral
fusion
properti
govern
entri
fit
vivo
analysi
clinic
strain
suggest
hnf
fusion
pair
circul
virus
maintain
balanc
properti
result
invers
correl
fusion
cultur
cell
growth
vivo
fusion
complex
oper
specif
constraint
govern
viabil
differ
environ
cell
cultur
human
be
previous
use
wholegenom
sequenc
field
strain
isol
human
grown
airway
cultur
analyz
divers
common
circul
strain
sequenc
use
defin
function
structur
properti
protein
circul
strain
order
identifi
genet
basi
properti
confer
fit
field
laboratoryadapt
ci
airwaygrown
strain
share
basic
properti
hnf
fusion
bind
fusion
trigger
receptor
balanc
properti
step
share
across
ci
studi
differ
laboratori
strain
ci
fusion
pair
possess
lower
fusogen
decreas
f
activ
compar
laboratori
strain
carri
deep
genom
screen
pair
clinic
sampl
one
portion
sampl
sequenc
directli
patient
cultur
step
portion
expos
brief
cultur
viral
isol
immort
rhesu
monkey
kidney
rhmk
cell
standard
cell
line
use
clinic
laboratori
viru
identif
hypothes
even
brief
period
cultur
mutat
aris
hnf
fusion
complex
could
inform
featur
essenti
growth
human
would
stringent
select
cultur
evolut
upon
exposur
cultur
extraordinarili
rapid
almost
entir
limit
hn
protein
bioinformat
analys
exist
hn
sequenc
reveal
hn
mutat
aros
brief
exposur
cultur
almost
uniformli
found
consensu
sequenc
either
adapt
cultur
expos
found
sequenc
directli
clinic
sampl
deep
sequenc
newli
deriv
isol
clinic
sampl
reveal
onethird
isol
subpopul
hn
dimer
interfac
variant
reflect
consensu
sequenc
present
sequenc
obtain
directli
clinic
sampl
sequenc
use
defin
function
structur
properti
differ
laboratoryselect
circul
strain
order
identifi
genet
basi
properti
may
confer
fit
field
hn
mutat
identifi
respons
exposur
cultur
includ
novel
previous
observ
character
adapt
immort
cell
remark
mutat
map
dimer
interfac
receptor
bind
site
ii
hn
result
point
critic
role
region
entri
mechan
fit
vivo
deduc
smallerscal
mechanist
studi
residu
receptor
bind
site
ii
dimer
interfac
hn
influenc
hn
dimer
activ
f
shown
presenc
glutamin
posit
dimer
interfac
hn
increas
hn
oligomer
therebi
modul
f
trigger
hn
activ
trigger
f
viru
bear
mutat
hn
subject
growth
human
airway
rapidli
acquir
compensatori
mutat
reduc
fusion
trigger
reduc
hn
dimer
structur
analysi
footprint
dimer
interfac
show
hn
present
receptor
bind
site
ii
interfac
residu
contact
oppos
monom
face
howev
hn
compensatori
mutat
permit
growth
airway
dimer
interfac
footprint
show
decreas
point
contact
dimer
interfac
footprint
point
sever
residu
domain
whose
contact
oppos
monom
may
critic
key
function
govern
hn
receptor
bind
site
ii
emerg
mutat
brief
cultur
highlight
flexibl
hn
site
ii
adapt
new
condit
also
exquisit
constraint
viru
fusion
complex
respect
alter
environ
adjac
residu
dimer
interfac
make
contact
dimer
interfac
footprint
mention
residu
previous
shown
highli
conserv
clinic
strain
residu
previous
found
aspart
acid
laboratoryadapt
strain
associ
dramat
decreas
neuraminidas
activ
consist
overal
highreceptorcontacthighfus
laboratoryadapt
phenotyp
present
studi
mutat
emerg
brief
exposur
cultur
highlight
advantag
lower
neuraminidas
activ
reduc
receptor
cleavag
cultur
condit
versu
import
neuraminidas
human
infect
within
cluster
alter
cultur
adapt
residu
contact
oppos
monom
dimer
interfac
cluster
precis
role
residu
function
dimer
region
explor
strikingli
sever
mutat
emerg
residu
opposit
side
hn
dimer
interfac
cluster
posit
residu
point
contact
oppos
hn
monom
dimer
interfac
footprint
note
correl
fusion
promot
airway
adapt
howev
function
residu
unexplor
select
absenc
mutat
domain
posit
suggest
newli
identifi
import
region
hn
dimer
interfac
may
act
independ
receptor
bind
site
ii
function
relationship
two
site
explor
futur
studi
numer
deep
sequenc
viral
isol
also
demonstr
hn
variant
absenc
mutat
domain
posit
find
second
dimer
interfac
domain
undergo
rapid
select
background
authent
clinic
strain
suggest
may
relev
fit
airway
investig
biolog
signific
adapt
gener
singli
mutat
hn
molecul
background
wellcharacter
clinic
viru
hn
gener
recombin
virus
bear
hn
mutat
genet
background
brief
exposur
cultur
divers
strategi
result
increas
fusion
promot
hn
variant
test
perhap
unexpect
base
previou
hypothes
absolut
consist
rang
specif
mutat
specif
function
structur
differ
viru
arriv
increas
remark
individu
hn
mutat
confer
fit
recombin
viru
infect
immort
monolay
cultur
cell
spread
viru
cultur
compar
parent
wt
ci
explor
compon
hn
properti
contribut
enhanc
fusion
promot
infect
properti
emerg
hn
mutant
assess
neuraminidas
activ
hn
releas
receptorbear
target
cell
measur
balanc
receptor
avid
cleavag
shown
clinic
virus
compar
laboratori
strain
combin
high
neuraminidas
low
avid
low
f
trigger
result
lower
fusogen
hn
mutant
emerg
except
hn
decreas
neuraminidas
activ
interest
mutat
site
ii
affect
neuraminidas
enzymat
activ
sinc
site
known
possess
enzymat
activ
resid
bifunct
activ
site
one
mechanist
conjectur
explor
alter
interact
one
hn
site
site
ii
modul
function
site
shown
anoth
paramyxoviru
newcastl
diseas
viru
receptor
interact
hn
site
lead
activ
site
ii
data
may
suggest
unexplor
cross
talk
site
site
ii
could
alter
neuraminidas
activ
alloster
hn
reduc
releas
rbc
compar
clinic
strain
hn
mutant
decreas
releas
rbc
face
increas
neuraminidas
activ
rel
ci
wt
agreement
previou
find
mutat
confer
increas
receptor
avid
balanc
receptorcleav
activ
overal
retent
contact
interestingli
mutat
labadapt
hn
background
higher
neuraminidas
activ
support
notion
phenotyp
confer
site
may
modifi
context
genet
background
collect
pattern
enhanc
receptor
engag
increas
fusogen
confer
fit
vitro
genet
engin
virus
bear
individu
alter
hn
show
fit
growth
monolay
cultur
compar
wt
parent
less
fit
growth
hae
mutat
emerg
brief
viral
isol
process
thu
led
directli
fit
growth
monolay
cultur
interestingli
singl
mutat
minor
allel
requir
success
growth
cultur
although
sampl
studi
produc
least
one
nonsynonym
minor
allel
either
f
hn
protein
minor
allel
extrem
bias
toward
mutat
hn
f
protein
eight
ten
cultur
present
minor
allel
hn
protein
four
present
minor
allel
f
protein
support
critic
natur
hnf
fusion
complex
host
adapt
intriguingli
singl
mutat
hn
confer
fatal
growth
disadvantag
airway
model
despit
confer
fit
monolay
cultur
interest
determin
whether
accumul
sever
fusionskew
mutat
necessari
absolut
inabl
grow
airway
whether
sensit
experiment
system
ie
infect
vivo
would
respons
singl
alter
greater
dimer
interfac
disturb
genom
sequenc
present
provid
signific
resourc
futur
genom
epidemiolog
biochem
character
increas
number
publicli
avail
genom
obtain
full
genom
sequenc
coverag
estim
start
copi
found
rel
uniform
whole
viral
genom
coverag
achiev
pairedend
read
suggest
mani
sampl
could
sequenc
singl
miseq
run
wholegenom
viral
sequenc
clinic
sampl
technic
econom
feasibl
permit
investig
avoid
use
laboratoryadapt
strain
viru
immort
cultur
cell
line
deep
genomewid
screen
pair
clinic
sampl
viral
isol
allow
simpl
rapid
interrog
viral
evolut
context
multipl
clinic
strain
background
method
pursu
allow
discoveri
novel
hn
residu
interest
heretofor
identifi
base
consensu
sequenc
deep
sequenc
rapid
select
pressur
may
allow
discoveri
greater
number
novel
mutat
may
remov
popul
drift
competit
variant
subpopul
longer
select
period
yet
provid
clue
function
techniqu
comprehens
profil
singl
mutat
deep
mutat
scan
often
limit
use
singular
background
often
context
cultureadapt
strain
focu
singular
protein
result
consist
uncertainti
principl
virolog
act
attempt
studi
clinic
viral
sampl
commonli
perform
laboratori
procedur
viral
cultur
cell
line
affect
authent
viral
biolog
even
first
passag
virus
evolv
uniqu
cultur
shown
howev
extraordinarili
rapid
natur
evolut
cultur
even
without
passag
notabl
adapt
genotyp
could
found
minor
allel
deep
sequenc
clinic
sampl
viral
isol
increas
provis
deep
coverag
viral
genom
obtain
directli
clinic
sampl
due
diagnost
mng
experi
similar
one
outlin
critic
potenti
pathogen
virus
order
assess
whether
previou
viral
character
studi
appli
newli
sequenc
clinic
sampl
result
consist
notion
use
authent
cultur
model
better
reflect
growth
vivo
critic
understand
character
pathogenesi
specif
mutat
emerg
cultur
sampl
disturb
perspect
uncertainti
describ
provid
wealth
inform
hn
domain
may
critic
fit
human
focu
correl
emerg
hn
mutat
function
character
combin
hn
mutat
function
studi
pair
hn
labadapt
fusogen
f
protein
order
readili
discern
differ
hn
properti
ongo
studi
explor
potenti
epistat
interact
evolut
particular
interest
cluster
residu
around
uncov
critic
studi
interact
residu
oppos
monom
point
contact
domain
within
interfac
suggest
base
structur
data
relev
fusion
promot
futur
studi
address
function
hn
dimer
interfac
domain
fusion
cell
entri
term
clinic
sampl
use
describ
primari
nasal
swab
viral
transport
media
viral
isol
cultur
isol
use
describ
cultur
harvest
zero
passag
viru
ie
brief
exposur
cultur
viral
isol
pair
clinic
samplecultur
isol
sequenc
nasal
swab
viral
transport
medium
nine
patient
cycl
threshold
ct
inocul
onto
primari
rhesu
monkey
kidney
rhmk
cell
quidel
diagnost
incub
roller
drum
tube
assess
cytopath
effect
daili
confirm
via
hemadsorpt
guinea
pig
red
blood
cell
rbc
posit
cultur
harvest
store
deidentifi
bronchial
alveolar
lavag
bal
fluid
nasal
swab
sampl
patient
use
prior
clinic
test
store
subject
mng
addit
cultur
harvest
viral
isol
perform
prior
clinic
test
bal
fluid
sampl
nasal
swab
sputum
sampl
univers
washington
virolog
laboratori
also
store
subject
mng
cultur
harvest
perform
use
protocol
detail
pair
sequenc
experi
use
excess
deidentifi
clinic
specimen
approv
local
univers
washington
institut
review
board
irb
protocol
sampl
metadata
includ
genbank
access
number
consensu
genom
avail
tabl
supplement
materi
associ
ncbi
bioproject
mng
perform
previous
describ
rna
extract
thaw
cultur
harvest
clinic
sampl
use
zymo
viral
rna
kit
zymo
research
treat
turbo
dnase
thermo
fisher
min
doublestrand
cdna
made
use
random
hexam
superscript
iii
revers
transcriptas
thermo
fisher
sequenas
thermo
fisher
clean
use
dna
clean
concentr
zymo
research
mng
librari
produc
ad
onethird
volum
nexteraxt
illumina
finish
cycl
dualindex
pcr
amplif
clean
use
ampur
bead
beckman
coulter
librari
sequenc
use
one
two
run
illumina
miseq
system
librari
match
viral
isol
prepar
twice
independ
librari
prepar
sequenc
run
control
artifact
librari
prepar
amplicon
sequenc
perform
investig
linkag
mutat
recov
mng
revers
transcriptionpcr
rtpcr
perform
use
cycl
default
paramet
melt
temperatur
tm
onestep
rtpcr
kit
qiagen
pcr
primer
f
stand
forward
r
stand
revers
amplicon
purifi
use
ampur
bead
dualindex
truseq
librari
prepar
use
kapa
hyperprep
kit
eight
cycl
pcr
amplif
sequenc
read
adapt
qualiti
trim
use
cutadapt
align
refer
sequenc
geneiou
consensu
genom
extract
origin
patient
sampl
cultur
sampl
sequenc
read
align
sampl
consensu
consensu
genom
visual
mutat
minor
allel
coverag
minor
allel
frequenc
maf
call
use
geneiou
known
locu
rna
edit
phosphoprotein
gene
includ
among
variant
nonsynonym
allel
adenosin
deaminaselik
chang
present
strand
viru
affect
minor
variant
tabl
phylodynam
analysi
code
nucleotid
sequenc
newli
gener
genom
sequenc
extract
concaten
align
use
geniou
mafft
result
align
use
gener
bayesian
skylin
tree
uncorrel
relax
clock
hasegawa
kishino
yano
hki
substitut
model
gamma
plu
invari
site
heterogen
model
four
gamma
categori
three
codon
partit
beast
markov
chain
mont
carlo
mcmc
length
iter
tree
gener
trace
inform
evolutionari
clock
rate
gather
analyz
use
tracer
result
tree
annot
compil
use
treeannot
annot
scale
figtre
phylodynam
protocol
also
perform
complet
genom
present
ncbi
nt
august
recombin
detect
perform
use
rdp
chimaera
maxchi
genecov
siscan
algorithm
default
set
determin
whether
cultureassoci
hn
amino
acid
chang
present
pair
sampl
sequenc
download
partial
complet
hn
sequenc
ncbi
nt
august
metadata
whether
specif
sequenc
origin
clinic
sampl
cultur
materi
gather
ncbi
genbank
sequenc
record
associ
manuscript
pubm
howev
alway
possibl
determin
whether
brief
exposur
cultur
condit
prior
sequenc
show
background
hn
protein
sequenc
could
influenc
amino
acid
mutat
select
cultur
major
consensu
amino
acid
sequenc
hn
protein
put
clinic
sampl
extract
align
use
mafft
neighborjoin
tree
creat
use
geniou
tree
build
algorithm
jukescantor
distanc
method
replic
hn
mutant
examin
studi
gener
sitedirect
mutagenesi
previous
construct
pcagg
mammalian
express
vector
hn
gene
plasmid
sanger
sequenc
confirm
prior
usag
transfect
plasmid
perform
hek
cell
use
lipofectamin
accord
manufactur
instruct
cell
surfac
express
hn
measur
standard
immunofluoresc
assay
procedur
use
monoclon
antibodi
hn
use
normal
appropri
two
monoclon
antihn
antibodi
use
custommad
aldevron
use
dna
immun
briefli
cdna
encod
hn
clone
express
plasmid
pegfp
group
laboratori
rat
wistar
immun
intraderm
applic
dnacoat
gold
particl
use
handheld
devic
particl
bombard
gene
gun
serum
sampl
collect
seri
immun
test
flow
cytometri
hek
cell
transient
transfect
express
plasmid
antibodyproduc
cell
isol
fuse
mous
myeloma
cell
accord
standard
procedur
abil
individu
hn
promot
fusion
measur
complement
assay
previous
describ
hn
pair
f
protein
labadapt
strain
transient
transfect
hek
cell
cell
fusion
quantifi
labadapt
f
partner
molecul
use
previous
describ
sinc
fusion
minim
ci
hn
f
express
pair
allow
quantit
comparison
neuraminidas
activ
hn
measur
previous
describ
hek
cell
transient
transfect
individu
hn
collect
detach
mm
edta
wash
dulbecco
phosphatebuff
salin
dpb
supplement
gliter
dglucos
mgliter
sodium
pyruv
gibco
resuspend
medium
ph
gibco
cell
ad
acid
sodium
salt
hydrat
ratio
final
concentr
mm
fluoresc
measur
everi
min
h
micropl
reader
tecan
abil
hn
releas
bound
rbc
measur
describ
previous
rbc
bound
cell
min
wash
remov
unbound
rbc
medium
ph
ad
cell
cell
incub
appropri
time
collect
replac
next
time
point
min
rbc
remain
bound
cell
lyse
ack
ammoniumchloridepotassium
lyse
buffer
gibco
quantifi
measur
absorb
nm
african
green
monkey
kidney
human
kidney
epitheli
cell
grown
dulbecco
modifi
eagl
medium
dmem
cellgro
mediatech
supplement
fetal
bovin
serum
fb
antibiot
clinic
isol
egfp
recombin
viru
gener
plasmid
code
major
consensu
sequenc
obtain
deep
sequenc
contain
enhanc
green
fluoresc
protein
egfp
express
cassett
p
viral
gene
mutant
deriv
uniqu
sequenc
recombin
virus
gener
revers
genet
background
use
modif
method
previous
describ
briefli
cell
seed
sixwel
plate
follow
day
cell
transfect
use
profect
mammalian
transfect
system
calcium
phosphat
kit
promega
accord
manufactur
recommend
pflc
plasmid
encod
fulllength
viral
genom
ng
p
ng
l
ng
n
ng
polymeras
ng
labadapt
hn
ng
labadapt
f
follow
day
supernat
fluid
replac
dmem
supplement
fb
two
day
transfect
cell
mechan
detach
pipet
overlaid
onto
cell
cultur
dish
cultur
cell
monitor
fluoresc
microscopi
cell
infect
medium
replac
dmem
without
fb
cell
incub
day
supernat
fluid
collect
centrifug
g
min
aliquot
kept
use
recombin
virus
sequenc
stage
use
mng
method
detail
supernat
fluid
confirm
correct
ci
backbon
hn
mutat
sequenc
use
experi
hae
epiairway
system
mattek
corpor
consist
normal
humanderiv
tracheobronchi
epitheli
cell
cultur
form
pseudostratifi
highli
differenti
mucociliari
epithelium
close
resembl
epitheli
tissu
vivo
upon
receipt
manufactur
human
airway
epithelium
hae
cultur
transfer
sixwel
plate
contain
ml
medium
per
well
apic
surfac
remain
expos
air
incub
hae
cultur
infect
pfu
recombin
clinic
isol
egfp
refer
apic
surfac
min
wild
type
wt
harbor
singl
mutat
hn
ie
use
min
medium
contain
inoculum
remov
cultur
place
fed
day
ml
medium
via
basolater
surfac
virus
harvest
ad
phosphatebuff
salin
pb
calcium
magnesium
chlorid
mattek
corpor
per
well
hae
cultur
apic
surfac
equilibr
min
suspens
collect
viral
titer
determin
previous
describ
viral
collect
perform
sequenti
well
cell
indic
day
postinfect
cultur
seed
plate
seventi
percent
confluent
cell
infect
pfu
recombin
wt
harbor
singl
mutat
hn
ie
apic
surfac
min
min
medium
contain
inoculum
replac
ml
dmem
supplement
fb
supernat
fluid
collect
aliquot
replac
volum
dmem
supplement
fb
viral
titer
determin
previous
describ
viral
collect
perform
sequenti
well
cell
indic
day
postinfect
